SAN FRANCISCO, Jan. 29, 2014 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTCQB:TAUG) or ("Tauriga" or "the Company"), a diversified company focused on generating profitable revenues through license agreements and the development of a proprietary technology platform in the nano-robotics space, today announced that its Pilus Energy LLC ("Pilus Energy") subsidiary has been selected as one of 50 Top Innovators to present at Venture Summit West 2014. This showcase will take place on February 12, 2014 at the Computer History Museum in Mountain View, California (Silicon Valley). Presenting on behalf of Pilus Energy LLC will be Dr. Stella M. Sung, Chief Operating Officer ("COO") of its parent company Tauriga Sciences, Inc. The extensive list of attending institutional investors and VC firms will provide Pilus Energy with a valuable opportunity to showcase its cutting edge solution to the joined global issues of water and energy.
The Second annual Venture Summit West, presented by youngStartup Ventures, is the premier industry gathering connecting venture capitalists, corporate VCs, angel investors, technology transfer professionals, senior executives of early stage and emerging growth companies, university researchers, incubators and premier service providers. For more information please visit the official conference website at (http://www.youngstartup.com/west2014/overview.php).
Tauriga's COO Dr. Stella M. Sung commented, "We are delighted to present the Pilus Energy synthetic biology-based 'waste-to-value' approach at the Venture Summit West. This is the ideal forum to showcase our innovative technology to leading venture capitalists and institutional investor focused on potentially disruptive emerging technologies."
Partial List of Institutional Investors and VCs Confirmed to Attend:
Dan Ahn, Managing Director, Voyager Capital | Julien CreuzÉ, Senior Associate, Aster Capital | Duncan Dashiff, Co-Founder & Managing Director, Epiphany Health Ventures | Stephen DeBerry, Chief Investment Officer, Bronze Investments | Andy Donner, Investment Director, Unilever Ventures | Ted Driscoll, Partner, Claremont Creek Ventures | Michael Dybbs, Principal, New Leaf Venture Partners | Andrew Farquharson, Managing Director, InCube Ventures | Mark Gorenberg, Managing Director, Hummer Winblad Venture Partners | Tim Guleri, Managing Director, Sierra Ventures | Mike Hammons, Partner, Sail Capital Partners | Nathaniel Henshaw, Managing Director, CEI Ventures | Caribou Honig, Founding Partner, QED Investors | David Hornik, General Partner, August Capital | Nadeem Kassam, Director, Zynik Capital | John Kim, Managing Partner, Highbar Partners | Yoav Andrew Leitersdorf, Managing Partner, YL Ventures | Noah Lichtenstein, Partner, Cowboy Ventures | John Loiacono, Venture Partner & Market Strategist | Jim Long, Partner, Gabriel Venture Partners | Jeb Miller, General Partner, Jafco Ventures | Peter Moran, General Partner, DCM | Umesh Padval, Partner, Bessemer Venture Partners | Renata Quintini, Partner, Felicis Ventures | Bill Reichert, Managing Director, Garage Technology Ventures | Lisa Rhoads, Managing Director, Easton Capital Investment Group | Rosemary Ripley, Managing Director, NGEN Partners | Miriam Rivera, Co-Founder & Managing Partner, Ulu Ventures | Mary Rozenman, Vice President, Longitude Capital | Ned Scheetz, Managing Director & Founder, Aphelion Capital | Rupam Shrivastava, Director, ePlanet Capital | David Siemer, Managing Partner, Siemer Ventures | Michael Staton, Partner, Learn Capital | Mark Silverman, Partner, Catamount Ventures | John Steuart, Managing Director, Prolog Ventures | Bruce Taragin, Managing Director, Blumberg Capital | Sharon Wienbar, Partner, Scale Venture Partners and many more.
On January 28, 2014 the Company completed its acquisition of Cincinnati, Ohio based Pilus Energy LLC ("Pilus Energy"), a developer of alternative cleantech energy platforms using proprietary microbial solutions that creates electricity while consuming polluting molecules from wastewater. Accordingly, Pilus Energy now operates a wholly-owned subsidiary of Tauriga Sciences, Inc.
About Tauriga Sciences, Inc.:
Tauriga Sciences, Inc. (TAUG) is a diversified company focused on generating profitable revenues through license agreements and the development of a proprietary technology platform in the nano-robotics space. The mission of the Company is to acquire and build a diversified portfolio of cutting edge technology assets that is capital efficient and of significant value to the shareholders. The Company's business model includes the acquisition of licenses, equity stakes, rights on both an exclusive and non-exclusive basis, and entire businesses. Management is firmly committed to building lasting shareholder value in the short, intermediate, and long terms. On January 28, 2014 the Company completed its acquisition of Cincinnati, Ohio based Pilus Energy LLC ("Pilus Energy"), a developer of alternative cleantech energy platforms using proprietary microbial solutions that creates electricity while consuming polluting molecules from wastewater. The Company's corporate website can be found at (www.tauriga.com).
About Pilus Energy LLC
A developer of alternative cleantech energy solutions, Pilus Energy is developing microbial solutions that clean polluting molecules from wastewater. In the process, the technology generates electricity and produces economically important gases and chemicals. Pilus Energy licenses a low-cost, scalable electrogenic bioreactor platform and wastewater-to-value BactoBots. Pilus Energy will also derive additional revenues from carbon and renewable energy credits (REC). Pilus Energy is a wholly-owned subsidiary of Danbury, CT based Tauriga Sciences, Inc. (OTCQB:TAUG). For more information, please visit Pilus Energy's web site, (www.pilusenergy.com).
Forward-Looking Statements: Except for statements of historical fact, this news release contains certain "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995, including, without limitation expectations, beliefs, plans and objectives regarding the development, use and marketability of products. Such forward-looking statements are based on present circumstances and on TAUG's predictions with respect to events that have not occurred, that may not occur, or that may occur with different consequences and timing than those now assumed or anticipated. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, and are not guarantees of future performance or results and involve risks and uncertainties that could cause actual events or results to differ materially from the events or results expressed or implied by such forward-looking statements. Such factors include general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to fund operations and other factors over which TAUG has little or no control. Such forward-looking statements are made only as of the date of this release, and TAUG assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. Readers should not place undue reliance on these forward-looking statements. Risks, uncertainties and other factors are discussed in documents filed from time to time by TAUG with the Securities and Exchange Commission. This press release does not and shall not constitute an offer to sell or the solicitation of any offer to buy any of the securities, nor shall there be any sale of the securities, in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state. The securities have not been registered under the Securities Act of 1933, as amended (the "Securities Act") or any state securities laws, and may not be offered or sold in the United States absent registration, or an applicable exemption from registration, under the Securities Act and applicable state securities laws.
CONTACT: Tauriga Sciences, Inc.:
Mr. Seth M. Shaw
Chairman & Chief Executive Officer
Tauriga Sciences, Inc.www.tauriga.comNew York: +1-917-796-9926
Source: Tauriga Sciences Inc